Post-earnings recap
Reported
Tue, Aug 7, 2012
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Charles River Laboratories reported an EPS of $0.75, exceeding expectations by 12.61%. However, the stock reacted negatively, declining by 0.73%. The lack of revenue data and management commentary may have contributed to investor uncertainty.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.75 | N/A | +12.61% |
No transcript is on record, and the analysis is based on numerical results only.